Madely Health Headlines Commentary for March 21, 2012
Primary source: The Lancet
Rothwell PR, et al “Short-term effects of daily aspirin on cancer incidence, mortalilty, and nonvascular death: Analysis of the time course of risks and benefits in 51 randomized controlled trials” Lancet 2012; DOI: 10.1016/S01450-6736(11)61720-0.
Additional source: The Lancet
Rothwell PM, et al “Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomized controlled trials” Lancet 2012; DOI: 10.1016/S0140-6736(12)60209-8.
Additional source: The Lancet Oncology
Rothwell PM, et al “Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomized trials” Lancet Oncol 2012; DOI: 10.1016/S1470-2045(12)70112-2.